Apa tegese "Clear"?
Kewan ora nindakake mutasi. Ora bakal ngembangake penyakit kasebut lan ora bakal ngliwati.
Kucing Kardiomiopati Hipertrofik ing Sphynx (HCM-Sphynx)
Hypertrophic Cardiomyopathy (HCM) in Sphynx cats is a common genetic heart condition that can lead to serious health issues. DNA testing for HCM in Sphynx cats helps identify carriers and affected cats early, enabling responsible breeding decisions. This test detects mutations linked to HCM, allowing owners and breeders to manage the risk effectively. Early diagnosis through DNA testing improves the chances of timely treatment and better quality of life. If you own or breed Sphynx cats, HCM DNA testing is essential for preventing the spread of this hereditary disease. Ensure your Sphynx cat’s heart health by opting for reliable genetic screening today. Protect your feline companion with accurate HCM DNA testing.
Singkatan : HCM-Sphynx
Analisa mutasi: ALMS1 c.7384G>C
Warisan : Autosomal dominan
Akronim
HCM-Sphynx
Frekuensi sing diamati
Keruwetan klinis
Klasifikasi klinis
Penyakit Kardiovaskular
Mutasi sing dianalisis
ALMS1 c.7384G>C
p.(G2462R)
p.(G2462R)
Mode warisan
Autosomal dominan (Incomplete)
Ringkesan tes:
Hypertrophic Cardiomyopathy (HCM) is a common heart condition in Sphynx cats, characterized by thickening of the heart muscle. A DNA test can help identify genetic mutations linked to HCM, allowing early detection and management. This test is crucial for breeders to reduce the risk of passing the condition to offspring. Regular screening combined with genetic testing improves the overall health and lifespan of affected cats. Early diagnosis through DNA testing supports better treatment and care decisions.
Kasedhiya saka paket: Basic
Tes DNA iki kalebu wiwit saka paket kita Basic — lan uga bagéan saka ngemas Basic, Standard, Advanced, Complete.
Deleng Paket Tes DNA →Pilih paket sing paling cocog karo breeding utawa strategi kesehatan kewan sampeyan.
Understanding Hypertrophic Cardiomyopathy (HCM) in Cats
Hypertrophic Cardiomyopathy (HCM) is a prevalent heart condition in cats, particularly affecting the Sphynx breed. This genetic disorder is characterized by the thickening of the heart muscle, which can lead to various complications, including heart failure, arrhythmias, and even sudden cardiac death. HCM can be asymptomatic in the early stages, making it challenging for pet owners to recognize the condition until it has progressed significantly.
Genetic Basis of HCM
Research has identified that HCM in cats is often linked to specific genetic mutations. In Sphynx cats, a mutation in the MYBPC3 gene is commonly associated with the development of HCM. This gene plays a crucial role in the structure and function of cardiac muscle, and mutations can disrupt normal heart function, leading to the thickening of the heart walls.
Pentinge Tes DNA
DNA testing for HCM is an essential tool for breeders and cat owners. It allows for the identification of carriers and affected cats, which can inform breeding decisions and help reduce the incidence of HCM in future generations. Through genetic testing, breeders can make more informed choices to prioritize the health and well-being of their litters.
Clinical Signs of HCM
While some cats with HCM may show no obvious symptoms, others may exhibit clinical signs that include difficulty breathing, lethargy, reduced appetite, and sudden collapse. Regular veterinary check-ups and awareness of these signs are crucial for early detection and management of the condition.
Pilihan Manajemen lan Perawatan
Management of HCM in cats often involves a combination of lifestyle changes, regular veterinary monitoring, and, in some cases, medication. Drugs such as beta-blockers or calcium channel blockers may be prescribed to help manage symptoms and improve heart function. Dietary modifications and weight management can also play a role in the overall health of affected cats.
Kesimpulan
Hypertrophic Cardiomyopathy is a serious condition that impacts the health of Sphynx cats. Understanding the genetic factors, recognizing clinical signs, and utilizing DNA testing can significantly aid in the management and prevention of this heart disease. Awareness and proactive measures are essential for ensuring a healthy life for cats predisposed to HCM.
Jenis sing diakoni kanggo tes: Kardiomiopati Hipertrofik ing Sphynx (HCM-Sphynx)
- American Shorthair
- Exotic
- Exotic Shorthair
- Munchkin
- Scottish Fold
- Sphynx
🧬 Interpretation of genotypes HCM-Sphynx
Genotip
Status
🟡 N/N
Non-carrier - Ora Risk
🟡 N/HCM-Sphynx
Carrier - Ing Risk
❌ HCM-Sphynx/HCM-Sphynx
Kena pengaruh - Risk
FAQ: mangerteni interpretasi
Apa "Carrier" serius?
Ora. Kewan iki umume sehat nanging bisa nularake mutasi kasebut turunan.
Apa yen kewan "Kena pengaruh"?
Iki nggawa rong salinan mutasi. pratandha Clinical samesthine gumantung ing penyakit. Sampeyan kudu ora dikembangke.
Apa ana bedane antarane lanang / wadon?
Sawetara penyakit ana hubungane karo jinis, mula ekspresi kasebut beda-beda gumantung saka penyakit kasebut jinis kewan.
Prediksi Keturunan
N/N (non-pembawa)
N/HCM-Sphynx (Pembawa)
HCM-Sphynx/HCM-Sphynx (kena pengaruh)
FAQ Tes DNA
Apa sing dideteksi tes DNA iki?
This DNA test detects the mutation associated with Hypertrophic Cardiomyopathy In Sphynx (HCM-Sphynx) in order to identify clear, carrier, or at-risk animals.
Napa nguji kewan breeding?
Tes DNA mbantu para peternak ngrancang kawin sing luwih aman lan nyuda risiko nularake mutasi menyang turunane.
Apa mode warisan saka tes iki?
Mode warisan sing dilapurake kanggo tes iki yaiku Autosomal Dominant.
Mutasi endi sing dianalisis ing tes iki?
This test analyses the mutation ALMS1 c.7384G>C.
Apa kewan operator kudu kena pengaruh?
Ora mesthi. Interpretasi gumantung saka pola warisan lan genotipe sing diasilake.
Referensi
Meurs Kathryn M, Williams Brian G, DeProspero Dylan, Friedenberg Steven G, Malarkey David E, Ezzell J Ashley, Keene Bruce W, Adin Darcy B, DeFrancesco Teresa C, Tou Sandra. A deleterious mutation in the ALMS1 gene in a naturally occurring model of hypertrophic cardiomyopathy in the Sphynx cat. Orphanet J Rare Dis. 2021 Feb 27;16(1):108. doi: 10.1186/s13023-021-01740-5.